论文部分内容阅读
Objective:The aim of our study was to investigate the effect of bortezomib in combination with arsenic trioxide(As2O3) on the proliferation and apoptosis in the human multiple myeloma cell line KM3.Methods:KM3 cells were cultured with different concentrations of bortezomib, As2O3 alone or in combination for different times.Cell proliferation was analyzed by MTT assay, and the IC50 was calculated.Cell morphology was observed under the light microscope(using Wright-Giemsa stain) and electric microscope.Agarose gel electrophoresis was used to evaluate DNA content.Flow cytometry was used to examine Annexin V-FITC/PI stain and mitochondrial transmembrane electric potential(ΔΨm).Results:Bortezomib and As2O3 alone both inhibited KM3 cell proliferation in a time and dose dependent manner, with the IC50 were 0.27, 3.10 μmol/L, respectively;the inhibiting rate on KM3 cells of bortezomib plus As2O3 was significantly higher than bortezomib alone(18.22 ± 1.04)% vs.(13.18 ± 1.29)%, P < 0.05;A series of typical morphological features of apoptosis and a typical DNA ladder were observed in KM3 cell treated with 0.25 μmol/L bortezomib for 48 h, which showed increased Annexin V positivity and decreased ΔΨm.The apoptosis rate induced by bortezomib plus As2O3 was also significantly than that of induced by bortezomib alone.Conclusion:Bortezomib could inhibit the proliferation while induce apoptosis of KM3 cells which may be through decreased ΔΨm.Bortezomib had enhanced inhibitory effect with As2O3 on the growth of KM3 cell(P < 0.05).As2O3 enhances the apoptosis effects of bortezomib on KM3 cell.
Objective: The aim of our study was to investigate the effect of bortezomib in combination with arsenic trioxide (As2O3) on the proliferation and apoptosis in the human multiple myeloma cell line KM3.Methods: KM3 cells were cultured with different concentrations of bortezomib, As2O3 alone or in combination for different times. Cell proliferation was analyzed by MTT assay, and the IC50 was calculated. Cell morphology was observed under the light microscope (using Wright-Giemsa stain) and electric microscope. Acegar gel electrophoresis was used to evaluate DNA content. Flow cytometry was used to examine Annexin V-FITC / PI stain and mitochondrial transmembrane electric potential (ΔΨm). Results: Bortezomib and As2O3 alone both inhibited KM3 cell proliferation in a time and dose dependent manner, with the IC50 were 0.27, 3.10 μmol / L, respectively; the inhibition rate on KM3 cells of bortezomib plus As2O3 was significantly higher than bortezomib alone (18.22 ± 1.04)% vs. (13.18 ± 1.29)%, P <0.05; A s eries of typical morphological features of apoptosis and a typical DNA ladder were observed in KM3 cell treated with 0.25 μmol / L bortezomib for 48 h, which showed increased Annexin V positivity and decreased ΔΨm.The apoptosis rate induced by bortezomib plus As2O3 was also significantly more than that of induced by bortezomib alone. Confc: Bortezomib could inhibit the proliferation while KM3 cells (FIG. 2) inhibited the proliferation of KM3 cells which could be through decreased ΔΨm.Bortezomib had enhanced inhibitory effect with As2O3 on the growth of KM3 cells effects of bortezomib on KM3 cell.